SEC Comment Letter for Altimmune, Inc. (ALT) (CIK 0001326190) (ALT) — Apr 15, 2019

Altimmune, Inc. (ALT) (CIK 0001326190)
Date: April 15, 2019 · CIK: 0001326190 · Accession: 0000000000-19-007165

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-230723

Date

April 11, 2019

Author

Vipin Garg

Form

UPLOAD

Company

Altimmune, Inc. (ALT) (CIK 0001326190)

Letter

April 11, 2019 Vipin Garg Chief Executive Officer Altimmune, Inc. 910 Clopper Road, Suite 201S Gaithersburg, MD Re:Altimmune, Inc. Registration Statement on Form S-3 Filed April 4, 2019 File No. 333-230723 Dear Dr. Garg: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joe McCann at 202-551-6262 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text

April 11, 2019
Vipin Garg
Chief Executive Officer
Altimmune, Inc.
910 Clopper Road, Suite 201S
Gaithersburg, MD
Re:Altimmune, Inc.
Registration Statement on Form S-3
Filed April 4, 2019
File No. 333-230723
Dear Dr. Garg:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Joe McCann at 202-551-6262 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance

SecProbe.io